Ensuring Complete Renal Clearance and Non-Cytotoxic Biodegradation of In-Vivo Nanorobots

Core clinical engineering and protocols for Biocompatibility & Clearance.

The Risk of Long-Term Nanomaterial Accumulation

Non-biodegradable nanomaterials that persist indefinitely in liver and spleen tissues risk chronic granulomatous inflammation, cytotoxicity, and long-term carcinogenicity, disqualifying them from clinical regulatory approval.

Engineered Biodegradation Pathways

HealthNanorobots utilizes superparamagnetic iron oxide nanoparticles (SPIONs) coated with bio-absorbable polymers. Once their drug delivery mission is accomplished, the particles dissolve into physiological iron ions that enter the body's natural iron metabolism pathways, while polymeric fragments under 5.5 nm are cleanly excreted through the kidneys.

헬스케어 도메인 포트폴리오 살펴보기